DAWN vs AAPL · rev $131.2M vs P/E 39, rev $416.16B
Day One Biopharmaceuticals Inc (DAWN) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
DAWN currently screens at market cap $656.8M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the DAWN and AAPL stock pages for the full models.
Not investment advice.